Since its founding in 1985, the American Foundation for AIDS Research (AmFAR) has become well known among biomedical scientists as a funding agency dedicated to seeding research relevant to HIV/AIDS. In recent months the foundation--which has major divisions in New York and Los Angeles and a public policy office in Washington, D.C.--has launched an initiative to fund research and education related to tuberculosis, as well.
TB, again becoming a major threat to public health, is "one more opportunistic infection" that contributes to the fatalities of AIDS patients, says Craig A. Rosen, the department chairman for gene regulation at the Roche Institute of Molecular Biology in Nutley, N.J., and head of AmFAR's Scientific Advisory Committee.
Bernard A. Dempsey, Jr., AmFAR's grants officer in Los Angeles, says that the foundation is currently preparing a request for proposals focusing on diagnostic tests and studies of multi-drug-resistant strains of TB. He says that $300,000...
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?